1. Pharmaceutics 2 & 3 صيدلانيات 2&3 Unit 4 2015 / second semester Transdermal drug delivery system

2.  Novel drug delivery systems, 2 nd edition, by Y.W. Chein page no.: 338 – 380. 2 REFERENCES Transdermal drug delivery system

3. Definition: Transdermal drug delivery is defined as a self contained discrete dosage form, which when applied to the intact skin, will deliver the drug at a controlled rate to the systemic circulation. 3 Transdermal drug delivery system

4. POTENTIAL BENEFITS OF TRANSDERMAL DRUG DELIVERY (ADVANTAGES) Easy to use. Avoid GIT absorption problems for drugs. Avoids FP hepatic metabolism of drugs. More improved and convenient patient compliance. Rapid termination in case of toxicity is possible. Self medication is possible. Reduces frequency of dosing. Maintains therapeutic level for 1 to 7 days. Controlled delivery resulting in more reliable and predictable blood levels. 4

5. DISADVANTAGES Daily dose of more than 10mg is not possible. Local irritation is a major problem. Drug requiring high blood levels are unsuitable. Drug with long half life can not be formulated in TDDS. Uncomfortable to wear. May not be economical. Barrier function changes from person to person and within the same person. Heat, cold, sweating (perspiring) and showering prevent the patch from sticking to the surface of the skin for more than one day. A new patch has to be applied daily. 5

6. 6 Routes of drug absorption through skin

7. FACTORS AFFECTING TRANSDERMAL PERMEABILITY  Physico chemical properties of parent molecule  Physico chemical properties of drug delivery system 7  Physiological and pathological condition of skin  Biological factors

8. BASIC COMPONENTS OF TRANSDERMAL DRUG DELIVERY SYSTEM COMPONENT OF TRANSDERMAL DEVICE INCLUDE: 1) POLYMER MATRIX 2) THE DRUG 3) PERMEATION ENHANCER 4) OTHER EXCEPIENTS 8

9. 9 Basic components of Transdermal drug delivery 9

10. Topical application-absorption & action of drugs SYSTEMIC DRUG IN TARGET TISSUE DRUG IN BLOOD CIRCULATION DISTRIBUTION ELIMINATION PHARMACOLOGICAL RESPONSE TOPICAL ABSORPTION DRUG IN DELIVERY SYSTEM DRUG IN SKIN SECRETION FLUIDS, SWEAT, SEBUM, pH 4.5--5.5 TRANSDERMAL LOCALIZED RELEASE 10

11. FORMULATION APPROACHES FOR DEVELOPMENT OF TRANSDERMAL DRUG DELIVERY SYSTEM 11

12. 1. POLYMER MEMBRANE PERMEATION CONTROLLED SYSTEM 12

13. 2. POLYMER MATRIX DIFFUSION CONTROLLED TDDS SYSTEM 13

14. 3. ADHESIVE DISPERSION-TYPE SYSTEM 14

15. 4. GRADIENT CONTROLLED TDDS Drug – impermeable metallic plastic laminate Drug reservoir gradient layers R 1 >R 2 >R 3 R1R1 R1R1 R2R2 R3R3 } 15

16. 5. MICRORESERVIOR TYPE OR MICROSEALED DISSOLUTION CONTROLLED SYSTEM rim 16

17. ADVANCED RESEARCHES MICROARRAY NEEDLE  Advanced micro-needle Patch transdermal system allowing continuous delivery through the skin of proteins and water-soluble drugs. 17

18. The device create painlessly micropores in the S.C. known as microstructered arrays or microneedles. These devices have about 400 microneedles. The solid silicone needles (coated with drug) or hollow metal needles (filled with drug solution) penetrate the horny layer without breaking it or stimulating nerves in deeper tissues. Flux increase up to 1,00,000 fold are reported. 18 ADVANCED RESEARCHES

19. 19 MICRONEEDLE ARRAY

20. 20 Find an appropriate place to put the patch